Pharmacokinetics, Efficacy and Safety Evaluation of FRSW107 in Previously Treated Hemophilia a Patients: A Multicentre, Open-Label, Non-Randomized Phase III Study
Year: 2022
Type: article
Study design: Clinical Trial
Source: Blood
Authors: Feng Xue, Hu Zhou, Yun Chen, Jing Sun, Xiaojing Zeng, Chenghao Jin, Pingchong Lei, Zhenyu Li, Yaming Xi, Lirong Sun, Zhongguang Cui, Xielan Zhao, Linhua Yang, Bangshuo Zhang, Aizong Shen, Runhui Wu, Xiaolin Wang, Ling Liu, Yuhua Wang, Lizhi Sun, Yan Xia, Weichuan Mo, Dong Yuan, Jiwei Lou, Taiping Gan, Chengli Hu, Chen Ling, Hongsheng Su, Yali Wang, Baolin Tang, Renchi Yang
Institutions: Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of Hematology & Blood Diseases Hospital, State Key Laboratory of Experimental Hematology, Zhengzhou University, Henan Cancer Hospital, Jinan Central Hospital, Nanfang Hospital, Southern Medical University, Affiliated Hospital of Guizhou Medical University, Jiangxi Provincial People's Hospital, Henan Provincial People's Hospital, Affiliated Hospital of Xuzhou Medical College, First Hospital of Lanzhou University, Affiliated Hospital of Qingdao University, Central South University, Xiangya Hospital Central South University, Shanxi Medical University, Second Hospital of Shanxi Medical University, Chongqing Three Gorges Central Hospital, Anhui Provincial Hospital, Beijing Children’s Hospital, Second Affiliated Hospital of Guangzhou Medical University, University of Science and Technology of China
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4310103502